Dongyue Li

发表

Strategies for the design of HIV-1 non-nucleoside reverse transcriptase inhibitors: lessons from the development of seven representative paradigms.

Peng Zhan, E. De Clercq, P. Zhan, 2012, Journal of medicinal chemistry.

HIV‐1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design

Peng Zhan, Xuwang Chen, Zengjun Fang, 2013, Medicinal research reviews.

Benzimidazole Heterocycle as a Privileged Scaffold in Antiviral Agents

P. Zhan, Xinyong Liu, Dongyue Li, 2012 .

Functional roles of azoles motif in anti-HIV agents.

E. De Clercq, P. Zhan, Xinyong Liu, 2011, Current medicinal chemistry.

Arylazolyl(azinyl)thioacetanilides. Part 10: design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitors.

Peng Zhan, Jan Balzarini, Xuwang Chen, 2012, Bioorganic & medicinal chemistry.

Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides as potent HIV-1 inhibitors.

E. De Clercq, C. Pannecouque, P. Zhan, 2011, European journal of medicinal chemistry.

Recent advances in DAPYs and related analogues as HIV-1 NNRTIs.

E. De Clercq, P. Zhan, Xinyong Liu, 2011, Current medicinal chemistry.

Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 2: discovery of novel [1,2,4]Triazolo[1,5-a]pyrimidines using a structure-guided core-refining approach.

Peng Zhan, Ye Tian, Christophe Pannecouque, 2014, European journal of medicinal chemistry.

Synthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIs.

Peng Zhan, Jan Balzarini, Christophe Pannecouque, 2013, Bioorganic & medicinal chemistry.

The Recent Advances of PARP Inhibitors in the Treatment of Cancer

Dongyue Li, 2023, Theoretical and Natural Science.